Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation

Completed · Phase 2/Phase 3

Conditions studied: Scorpion Sting Envenomation

In brief

This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailable. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of scorpion sting envenomation. 2. The investigational antivenom is effective as treatment of scorpion sting envenomation.

Key facts

Study ID
NCT00624078
Run by
Instituto Bioclon S.A. de C.V.
People needed
1426
Starts
2005-05-01
Expected to finish
2010-09-01
Last updated by the study team
2011-02-23

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.